Blue Fin Group (IntegriChain)

Overview

Management consulting firm focused on therapy commercialization strategy — market access, channel and distribution, GTN optimization, and patient services — acquired by IntegriChain in January 2022 and operating as its advisory division.

Notable

300+ life sciences manufacturers served across cell/gene, rare, specialty, and generics before acquisition.

Key services

Market access strategy
Channel & distribution strategy
GTN optimization
Commercialization strategy

Subcategories

Channel Distribution
GTN Contracting
Payer Strategy

Verified Reviews

No verified reviews yet — are you a customer of Blue Fin Group (IntegriChain)? Share your experience in a short, confidential interview.

Share your experience

Sources

https://www.integrichain.com/news/integrichain-acquires-blue-fin-group-combining-therapy-commercialization-expertise-with-leading-technology-data-and-business-operations/